BioMarin Pharmaceutical | Ventes





Ventes Changement Date
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 12.9M 450K 2025-09
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Amgen USD 9.9B 340M 2025-12
Bayer EUR 9.66B 1.08B 2025-09
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Gilead Sciences USD 7.8B 700M 2025-09
Incyte USD 1.37B 310M 2025-09
Insmed USD 142M 34.6M 2025-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
Moderna USD 1.02B 878M 2025-09
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
PTC Therapeutics USD 211M 32.1M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 12.2B 3.19B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
United Therapeutics USD 799.5M 900K 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


BioMarin Pharmaceutical Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.